Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Therapeutic Solutions International Inc TSOI

Therapeutic Solutions International, Inc. is focused on immune modulation for the treatment of several specific diseases. The Company is developing a range of immune-modulatory agents to target certain cancers, schizophrenia, suicidal ideation, and traumatic brain injury (TBI), and for daily health. Its flagship product, QuadraMune, is a multi-patented synergistic blend of pterostilbene... see more

OTCPK:TSOI - Post Discussion

View:
Post by jefftrade11 on Jan 25, 2021 4:11pm

Huge news!

Wow these guys never fail to impress. Todays news is further proof that these cellular medicines will be here to stay. From treating brain injuries, to cancer, to depression. The total market size for these therapies seems unlimited. With the huge roster of patents TSOI is sitting on a goldmine. Weather its commercilization, licensing, selling a patent, or total company buyout, this company has a very bright future. Can't wait to see whats next!
Be the first to comment on this post